 He wanted to see the biological history of the disease and prove that the best way to treat it was to attack any signs of the cancer before it became a serious issue.However, the Bowery Series lacked a control group of patients who were not biopsied, so he was unable to compare data with his experimentation group.He lacked any proof or evidence that the people treated were able to live longer, and were actually subjected to further health risks.